New York State Common Retirement Fund Point Biopharma Global Inc. Transaction History

New York State Common Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$6.67 - $9.71 $1,994 - $2,903	299 Added 1.11%	27,257 $182,000
Q2 2023 Aug 07, 2023	SELL	$6.86 - $10.86 $85,585 - $135,489	-12,476 Reduced 31.64%	26,958 $244,000
Q1 2023 May 02, 2023	SELL	$6.78 - $8.1 $87,502 - $104,538	-12,906 Reduced 24.66%	39,434 $287,000
Q4 2022 Jan 30, 2023	SELL	$5.72 - $9.78 $125 - $215	-22 Reduced 0.04%	52,340 $382,000
Q3 2022 Nov 08, 2022	BUY	$7.24 - $10.31 $4,792 - $6,825	662 Added 1.28%	52,362 $405,000
Q2 2022 Aug 04, 2022	BUY	$5.6 - $9.5 $289,520 - $491,150	51,700 New	51,700 $352,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.